Filter by Interests
Filter by ContentType
Spatial mapping: shaping the future of I-O diagnostics and treatment
Banafshé Larijani
06 December 2024
Interview
Advancing cellular therapies: moving beyond the CAR-T landscape
Frank Borriello
05 September 2024
Interview
Challenges and innovations in patient selection, biomarkers, and personalized treatments within the I-O landscape
Oliver Rosen
04 September 2024
Interview
The evolving landscape of combination therapies in lung cancer
Heather Wakelee
25 March 2024
Interview
Revolutionizing cancer treatment? A conversation on the potential of personalized cancer vaccines
Roy de Souza, David Hawke
20 March 2024
Interview
Developing novel radio immunotherapy combinations for lung cancer treatment
Joe Chang
12 March 2024
Interview
The preclinical journey: transitioning a novel cell therapy into early phase clinical trials
Silvio Manfredo-Vieira
06 March 2024
Interview
Combination therapies: a journey into personalized vaccine immunotherapeutics for early-stage cancers
Stephen Johnston
06 March 2024
Interview
Navigating genomics and transcriptomics in the immuno-oncology space
Katie Campbell
01 March 2024
Interview
Charting a course for the expanded application of mRNA vaccine technology
Myriam Mendila
23 February 2024
Interview
Delivering on the promise of mRNA cancer vaccines in the immuno-oncology clinical setting
Jane Healy
23 February 2024
Interview
Pioneering nucleic acid breakthroughs for the world
Robert Langer
23 February 2024
Interview
Wall Street analyst’s perspective: taking the pulse of the nucleic acid-based prophylactic & therapeutic vaccine sectors
Hartaj Singh
23 February 2024
Interview
Advancing combination therapies: a discussion on trials, challenges, and future goals
Aakash Desai
22 February 2024
Interview
The future of combination therapies in I-O: insights, challenges, & future endeavors
Roy Baynes
10 January 2024
Interview
Exploring the landscape of novel targets & pathways in immuno-oncology
Yvonne McGrath
06 December 2023
Interview
Key considerations in expanding global manufacture of a commercialized CAR-T cell therapy
Sarah Snykers
30 November 2023
Interview
Navigating the complexities of immunotherapy: unraveling novel targets & pathways
Lars van der Veen
29 November 2023
Interview
Enabling patient access to CAR-T cell therapy in India
Shashwati Basak
22 November 2023
Interview
Advancing immunotherapy and data-driven research
Jill O'Donnell-Tormey
22 November 2023
Interview
Balancing act: improving safety while retaining efficacy in I-O
Paolo Antonio Ascierto
08 November 2023
Interview